Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02593812 · ClinicalTrials.gov registry record · NA

The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT02593812 is a NA study of Parkinson Disease that has completed, run by University of Utah. The registered enrollment target is 27 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02593812, a NA study of Parkinson Disease, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The study determines whether standard medical care (dopamine) affects learning and retention of a postural stepping task in people with Parkinson's disease (PD) and whether training on a postural stepping task generalises to performance on an untrained postural task. Half the participants will train on the stepping task after they have taken their first dose of dopamine for the day (i.e. "on" medication state) while the other half will train on the same stepping task before taking their first daily dose of dopamine (i.e. "off" medication state).

Conditions Studied

Interventions

  • BEHAVIORAL Stepping training

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2016-07
Est. Completion 2017-05-11
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT02593812

The ClinicalTrials.gov registry entry for NCT02593812 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Stepping training is the first listed.

NCT02593812 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT02593812 about?

NCT02593812 is a clinical study titled "The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease". The study determines whether standard medical care (dopamine) affects learning and retention of a postural stepping task in people with Parkinson's disease (PD) and whether training on a postural stepping task generalises to performance on an untrained postural task. Half the participants will train...

What is the current status of trial NCT02593812?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-07. Estimated completion is 2017-05-11.

What conditions does trial NCT02593812 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT02593812?

The interventions under investigation include: Stepping training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02593812?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02593812 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.